Literature DB >> 29974381

Levo-tetrahydropalmatine Attenuates Neuron Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury: Involvement of c-Abl Activation.

Ruoxi Sun1,2, Yichen Song1,2, Shanshan Li1,2, Zhanqiang Ma1,2, Xueyang Deng1,2, Qiang Fu1,2, Rong Qu3, Shiping Ma4,5.   

Abstract

Ischemic stroke is one of the most dangerous acute diseases which causes death or deformity. Apoptosis has been shown to play an important role in the development and pathogenesis of cerebral ischemia-reperfusion injury (I/R injury), but the related mechanism is unclear. Levo-tetrahydropalmatine (L-THP), a bioactive ingredient extracted from the Chinese herb Corydalis, can penetrate the blood-brain barrier and exert various pharmacological effects on neural tissues. The present study examined the neuroprotective effect of L-THP on neuronal apoptosis induced by cerebral I/R injury. Results showed that pretreatment with L-THP (12.5, 25, and 50 mg/kg) improved neurological outcomes and reduced infarct volume and cerebral edema in comparison with the brains of the middle cerebral artery occlusion (MCAO) group. These findings provided evidence for the neuroprotective effects of L-THP against cerebral I/R injury. Furthermore, administration of L-THP enhanced the expression of Bcl-2 and attenuated the content of Bax, cleaved caspase-3, and PARP. L-THP could improve the reduction of NeuN-positive cells induced by I/R injury. These results suggested that L-THP could inhibit neuroapoptosis in cerebral ischemic rats. c-Abl was discovered as the critical protein responsible for neurocyte apoptosis; however, few data have been published on the relation between ischemic stroke and the expression of c-Abl. We found that both c-Abl expression and neuronal apoptosis were significantly increased in the MCAO group, while pretreatment with L-THP could ameliorate this effect. Therefore, we deduced that reduced c-Abl overexpression may play a role in the anti-apoptosis effect of L-THP after cerebral I/R injury. Thus, L-THP may provide a potential therapeutic approach for the treatment of ischemic stroke. Graphical Abstract ᅟ.

Entities:  

Keywords:  Apoptosis; C-Abl; Cerebral ischemia–reperfusion; L-THP; p38

Mesh:

Substances:

Year:  2018        PMID: 29974381     DOI: 10.1007/s12031-018-1063-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

1.  Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis.

Authors:  Y Ito; P Pandey; N Mishra; S Kumar; N Narula; S Kharbanda; S Saxena; D Kufe
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

Review 2.  The science of stroke: mechanisms in search of treatments.

Authors:  Michael A Moskowitz; Eng H Lo; Costantino Iadecola
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

3.  The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats.

Authors:  Kai Yue; Baomiao Ma; Qin Ru; Lin Chen; Yongping Gan; Daisong Wang; Guozhang Jin; Chaoying Li
Journal:  Pharmacol Biochem Behav       Date:  2012-03-27       Impact factor: 3.533

Review 4.  Signaling by ROS drives inflammasome activation.

Authors:  Fabio Martinon
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

5.  Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome.

Authors:  Xiangxiang Wang; Ruipeng Li; Xuan Wang; Qiang Fu; Shiping Ma
Journal:  Neurosci Lett       Date:  2015-06-10       Impact factor: 3.046

Review 6.  Structure and dynamic regulation of Abl kinases.

Authors:  Shoghag Panjarian; Roxana E Iacob; Shugui Chen; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2013-01-11       Impact factor: 5.157

7.  Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.

Authors:  S Karunakaran; V Ravindranath
Journal:  J Neurochem       Date:  2009-05-11       Impact factor: 5.372

8.  GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.

Authors:  Wei Wang; Mingchang Li; Yuefei Wang; Qian Li; Gang Deng; Jieru Wan; Qingwu Yang; Qianxue Chen; Jian Wang
Journal:  Mol Neurobiol       Date:  2015-12-15       Impact factor: 5.590

9.  Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.

Authors:  Jeff S Healey; Jonas Oldgren; Michael Ezekowitz; Jun Zhu; Prem Pais; Jia Wang; Patrick Commerford; Petr Jansky; Alvaro Avezum; Alben Sigamani; Albertino Damasceno; Paul Reilly; Alex Grinvalds; Juliet Nakamya; Akinyemi Aje; Wael Almahmeed; Andrew Moriarty; Lars Wallentin; Salim Yusuf; Stuart J Connolly
Journal:  Lancet       Date:  2016-08-08       Impact factor: 79.321

10.  Evaluation of the Therapeutic Potential of Anti-TLR4-Antibody MTS510 in Experimental Stroke and Significance of Different Routes of Application.

Authors:  Lena Andresen; Konstantina Theodorou; Sarah Grünewald; Bozena Czech-Zechmeister; Birte Könnecke; Fred Lühder; George Trendelenburg
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more
  8 in total

1.  c-Abl Tyrosine Kinase-Mediated Neuronal Apoptosis in Subarachnoid Hemorrhage by Modulating the LRP-1-Dependent Akt/GSK3β Survival Pathway.

Authors:  Cong Yan; Yao Liu; Hongwei Yu; Pei Wu; Chunlei Wang; Hongbo Zhao; Kongbin Yang; Qi Shao; Yingqiang Zhong; Wenyang Zhao; Jingwei Li; Nan Liu; Jinglong Di; Chen Li; Luhao Bao; Cheng Gao
Journal:  J Mol Neurosci       Date:  2021-03-30       Impact factor: 3.444

Review 2.  Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications.

Authors:  Hui Xu; Emily Wang; Feng Chen; Jianbo Xiao; Mingfu Wang
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

3.  Divergence and Convergence of Cerebral Ischemia Pathways Profile Deciphers Differential Pure Additive and Synergistic Mechanisms.

Authors:  Penglu Wei; Pengqian Wang; Bing Li; Hao Gu; Jun Liu; Zhong Wang
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

4.  Carthamin yellow improves cerebral ischemia‑reperfusion injury by attenuating inflammation and ferroptosis in rats.

Authors:  Huihui Guo; Lili Zhu; Pingping Tang; Dong Chen; Yancai Li; Jianbing Li; Chao Bao
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

Review 5.  Neuroprotective Effect for Cerebral Ischemia by Natural Products: A Review.

Authors:  Qian Xie; Hongyan Li; Danni Lu; Jianmei Yuan; Rong Ma; Jinxiu Li; Mihong Ren; Yong Li; Hai Chen; Jian Wang; Daoyin Gong
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 6.  A Comprehensive Review on the Chemical Properties, Plant Sources, Pharmacological Activities, Pharmacokinetic and Toxicological Characteristics of Tetrahydropalmatine.

Authors:  Qinyun Du; Xianli Meng; Shaohui Wang
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

7.  Endothelial-Dependent and Independent Vascular Relaxation Effect of Tetrahydropalmatine on Rat Aorta.

Authors:  Zhong-Yan Zhou; Wai-Rong Zhao; Wen-Ting Shi; Ying Xiao; Zi-Lin Ma; Jin-Gui Xue; Lun-Qing Zhang; Qing Ye; Xin-Lin Chen; Jing-Yi Tang
Journal:  Front Pharmacol       Date:  2019-04-16       Impact factor: 5.810

8.  Jiawei Foshou San Induces Apoptosis in Ectopic Endometrium Based on Systems Pharmacology, Molecular Docking, and Experimental Evidence.

Authors:  Jiahui Wei; Binxin Zhao; Chengling Zhang; Bingbing Shen; Ying Zhang; Changxi Li; Yi Chen
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-27       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.